Recent Finacing
Recent Raise
Revelation Biosciences is a clinical-stage life sciences company developing intranasal TLR4-targeting immunomodulators (REVTx-99, REVTx-200) for respiratory viruses and a rapid lateral-flow POC diagnostic (REVDx-501).
Focus Areas
Total Raised
Funding round
See the team members at Revelation Biosciences.
